| Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) M Ho, A Patel, CY Goh, M Moscvin, L Zhang, G Bianchi Leukemia 34 (12), 3111-3125, 2020 | 70 | 2020 |
| CD38 as an immunotherapeutic target in multiple myeloma F Bonello, M D’Agostino, M Moscvin, C Cerrato, M Boccadoro, F Gay Expert opinion on biological therapy 18 (12), 1209-1221, 2018 | 43 | 2018 |
| Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor T Vaisitti, F Gaudino, S Ouk, M Moscvin, N Vitale, S Serra, F Arruga, ... haematologica 102 (11), 1878, 2017 | 37 | 2017 |
| Exosomes in the pathogenesis and treatment of multiple myeloma in the context of the bone marrow microenvironment T Chen, M Moscvin, G Bianchi Frontiers in Oncology 10, 608815, 2020 | 31 | 2020 |
| Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival T Chen, M Ho, J Briere, M Moscvin, PG Czarnecki, KC Anderson, ... Blood Advances 6 (2), 429-440, 2022 | 19 | 2022 |
| ROBO1 promotes homing, dissemination, and survival of multiple myeloma within the bone marrow microenvironment G Bianchi, PG Czarnecki, M Ho, AM Roccaro, A Sacco, Y Kawano, ... Blood cancer discovery 2 (4), 338-353, 2021 | 12 | 2021 |
| Overcoming drug resistance by targeting protein homeostasis in multiple myeloma M Moscvin, M Ho, G Bianchi Cancer Drug Resistance 4 (4), 1028, 2021 | 10 | 2021 |
| Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy M Moscvin, CI Liacos, T Chen, F Theodorakakou, D Fotiou, S Hossain, ... Blood Cancer Journal 13 (1), 31, 2023 | 7 | 2023 |
| Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs X Liu, M Moscvin, S Oh, T Chen, W Choi, B Evans, SM Rowell, O Nadeem, ... Clinical and experimental medicine 23 (7), 3821-3832, 2023 | 3 | 2023 |
| Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma M Ho, M Moscvin, SK Low, B Evans, S Close, R Schlossman, J Laubach, ... Leukemia & lymphoma 63 (10), 2403-2412, 2022 | 3 | 2022 |
| Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy M Moscvin, CI Liacos, T Chen, F Theodorakakou, D Fotiou, E Regan, ... Blood 138, 2708, 2021 | 3 | 2021 |
| Dissecting molecular mechanisms of immune microenvironment dysfunction in multiple myeloma and precursor conditions M Moscvin, B Evans, G Bianchi Journal of cancer metastasis and treatment 9, 2023 | 1 | 2023 |
| OAB-042: Targeting free light chain secretion via Botulinum Neurotoxin is a novel therapeutic strategy in AL amyloidosis by inducing a terminal unfolded protein response M Moscvin, T Chen, P Czarnecki, A Gulla, K Anderson, G Bianchi Clinical Lymphoma Myeloma and Leukemia 21, S27-S28, 2021 | 1 | 2021 |
| Clonal Hematopoiesis of Indeterminate Potential in Patients with Immunoglobulin Light Chain AL Amyloidosis P Lopedote, B Evans, A Marchetti, T Chen, M Moscvin, S Boullt, N Bolli, ... Blood Advances, bloodadvances. 2024012840, 2024 | | 2024 |
| Immune Reconstitution and Infectious Complications Following BCMA-Targeted CAR-T Therapy in Relapsed/Refractory Multiple Myeloma (RRMM) M Moscvin, A Goyal, A Jensen, DJ Epstein, V Hovanky, L Mikkilineni, ... Transplantation and Cellular Therapy 30 (2), S315-S316, 2024 | | 2024 |
| Characterization of proteasome stress response reporter mammalian cell lines for the discovery of DDI2 inhibitors in multiple myeloma C VanCleave, T Chen, M Ho, M Moscvin, PG Czarnecki, G Bianchi MOLECULAR CANCER THERAPEUTICS 22 (12), 2023 | | 2023 |
| Abstract A126: Characterization of proteasome stress response reporter mammalian cell lines for the discovery of DDI2 inhibitors in multiple myeloma C VanCleave, T Chen, M Ho, M Moscvin, PG Czarnecki, G Bianchi Molecular Cancer Therapeutics 22 (12_Supplement), A126-A126, 2023 | | 2023 |
| Abstract B112: SNAP23-dependent SNARE complex is a novel molecular target in AL Amyloidosis and Multiple Myeloma by blocking free light chain secretion and triggering a … E Karayol, M Moscvin, T Chen, PG Czarnecki, A Gulla, KC Anderson, ... Molecular Cancer Therapeutics 22 (12_Supplement), B112-B112, 2023 | | 2023 |
| Acute Myeloid Leukemia with Inv (3) or t (3; 3): A Clinical and Cytogenetic Characterization of 40 Patients M Moscvin, M Schwede, G Mannis, TY Zhang Blood 142, 4231, 2023 | | 2023 |
| A SNAP23-Dependent SNARE Complex Mediates Free Light Chain Secretion in AL Amyloidosis and Multiple Myeloma and Its Blockade Triggers a Terminal Unfolded Protein Response and … E Karayol, M Moscvin, T Chen, PG Czarnecki, A Gulla, KC Anderson, ... Blood 142, 4662, 2023 | | 2023 |
